GSLC:LSE:LSE-Goldman Sachs ActiveBeta US Large Cap Equity UCITS ETF USD Acc (USD)

ETF | Others |

Last Closing

USD 82.66

Change

+0.38 (+0.46)%

Market Cap

USD 0.15B

Volume

933.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+0.40 (+0.20%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.10 (-0.71%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 640.06B
0R1I:LSE NVIDIA Corp.

-0.90 (-0.67%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

+0.02 (+0.06%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

+0.35 (+0.49%)

USD 266.08B
0QZO:LSE 0QZO

-0.20 (-0.18%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-2.50 (-1.64%)

USD 202.26B
0R24:LSE Intel Corp.

-0.25 (-1.16%)

USD 196.14B

ETFs Containing GSLC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.16% 56% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.16% 55% F 53% F
Trailing 12 Months  
Capital Gain 12.65% 81% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.65% 79% B- 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 13.97% 74% C 76% C+
Dividend Return 13.97% 73% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.34% 56% F 73% C
Risk Adjusted Return 113.19% 95% A 97% N/A
Market Capitalization 0.15B 56% F 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike